Related Experiment Videos
Ocular effects of beta-blocking therapy
Transactions of the Ophthalmological Societies of the United Kingdom
|September 1, 1977
Summary
Beta-blocking drugs, commonly used for various conditions, were evaluated for ocular side effects. This study found no significant adverse effects on the cornea, conjunctiva, or tear secretion in patients undergoing beta-blocker therapy.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Beta-blocking agents are widely prescribed for cardiovascular and other conditions.
- Ocular side effects associated with some medications necessitate careful evaluation.
Purpose of the Study:
- To assess the impact of beta-blocking drug therapy on ocular health.
- To investigate potential adverse effects on the cornea, conjunctiva, and lacrimal function.
Main Methods:
- Ophthalmological examinations were conducted on 192 patients receiving beta-blockers.
- A control group of 52 patients was included for comparison.
- Evaluated parameters included corneal and conjunctival status, and tear secretion.
Main Results:
- No significant adverse effects were observed in the cornea or conjunctiva of patients on beta-blockers.
- Tear secretion remained unaffected by beta-blocking drug therapy.
- Comparison with the control group showed no statistically significant differences.
Conclusions:
- Beta-blocking agents, excluding practolol, do not appear to cause significant ocular pathology.
- The study provides evidence against beta-blockers causing adverse effects on the anterior eye structures and tear film.
- Further research may be warranted for specific beta-blocking agents.